The global albumin market was valued at US$ 4.6 billion in 2020 and is projected to reach US$ 8.1 billion by the end of 2031, expanding at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2031. Increasing demand for plasma-derived therapies, rising investments in life sciences, and the growing use of albumin in pharmaceutical manufacturing are expected to support market expansion....
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek